Home › Compare › VPTDF vs ORCC

VPTDF vs ORCC: Dividend Comparison 2026

VPTDF yields 2312.14% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VPTDF wins by $38613850936.59M in total portfolio value
10 years
VPTDF
VPTDF
● Live price
2312.14%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38613850936.61M
Annual income
$35,586,201,922,515,856.00
Full VPTDF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — VPTDF vs ORCC

📍 VPTDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVPTDFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VPTDF + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VPTDF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VPTDF
Annual income on $10K today (after 15% tax)
$196,531.79/yr
After 10yr DRIP, annual income (after tax)
$30,248,271,634,138,476.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, VPTDF beats the other by $30,248,271,634,138,476.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VPTDF + ORCC for your $10,000?

VPTDF: 50%ORCC: 50%
100% ORCC50/50100% VPTDF
Portfolio after 10yr
$19306925468.32M
Annual income
$17,793,100,961,257,928.00/yr
Blended yield
92.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

VPTDF
No analyst data
Altman Z
-272.5
Piotroski
3/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VPTDF buys
0
ORCC buys
0
No recent congressional trades found for VPTDF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVPTDFORCC
Forward yield2312.14% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0% ✓-50%
Portfolio after 10y$38613850936.61M ✓$21.4K
Annual income after 10y$35,586,201,922,515,856.00 ✓$1.04
Total dividends collected$38401207511.77M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: VPTDF vs ORCC ($10,000, DRIP)

YearVPTDF PortfolioVPTDF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$241,914$231,213.87$11,190$489.61+$230.7K → VPTDF
2$5,486,310$5,227,462.00$12,229$256.01+$5.47M → VPTDF
3$116,667,010$110,796,658.85$13,216$130.74+$116.65M → VPTDF
4$2,326,799,779$2,201,966,078.24$14,207$66.02+$2326.79M → VPTDF
5$43,532,552,320$41,042,876,556.38$15,234$33.17+$43532.54M → VPTDF
6$764,223,950,336$717,644,119,353.02$16,317$16.62+$764223.93M → VPTDF
7$12,591,932,032,884$11,774,212,406,024.32$17,468$8.32+$12591932.02M → VPTDF
8$194,782,556,253,371$181,309,188,978,186.10$18,695$4.16+$194782556.23M → VPTDF
9$2,829,578,517,848,077$2,621,161,182,656,969.50$20,006$2.08+$2829578517.83M → VPTDF
10$38,613,850,936,613,300$35,586,201,922,515,856.00$21,407$1.04+$38613850936.59M → VPTDF

VPTDF vs ORCC: Complete Analysis 2026

VPTDF — Stock

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.

Full VPTDF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this VPTDF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VPTDF vs SCHDVPTDF vs JEPIVPTDF vs OVPTDF vs KOVPTDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.